Medicinal plants in India

Indian Journal of Medical Research

Volumn 120, Issue 1, 2004, Pages 9-11

  Seth, S D ^a   Sharma, Bhawana ^a  

^a Inst for Res in Medical Statistics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL ISOTHIOCYANATE; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; DIGITALIS EXTRACT; EPALTES DIVARICATA EXTRACT; FINASTERIDE; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; PLANT EXTRACT; SABAL EXTRACT; UNCLASSIFIED DRUG; PLANT MEDICINAL PRODUCT;

ANTIOXIDANT ACTIVITY; ASCITES; CLINICAL TRIAL; DEPRESSION; DRUG APPROVAL; DRUG CONTAMINATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG QUALITY; DRUG SAFETY; DRUG SCREENING; DYSPEPSIA; ECONOMIC ASPECT; EPALTES DIVARICATA; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; GEOGRAPHY; GOOD MANUFACTURING PRACTICE; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HERBAL MEDICINE; HERPES SIMPLEX; HUMAN; INDIA; JAUNDICE; LIVER TOXICITY; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MEDICINAL PLANT; NOTE; POSTMARKETING SURVEILLANCE; PROSTATE HYPERTROPHY; RISK BENEFIT ANALYSIS; RURAL AREA; SPECIES DISTRIBUTION; TRADITIONAL MEDICINE; VALIDATION PROCESS; AYURVEDA; DRUG EFFECT; LIVER; LIVER DISEASE; PHYTOTHERAPY;

HUMANS; INDIA; LIVER; LIVER DISEASES; MEDICINE, AYURVEDIC; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL;

EID: 4344583780     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (22)

1. Kamboj VP. Herbal medicine. Curr Med 2000; 78: 35-39.
2. Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 2004;116: 478-85.
3. Dubey N K, Kumar.R, Tripathi P. Global promotion of herbal medicine: India's opportunity. Curr Med 2004; 86: 37-41.
4. Ahmedullah M, Nayar MP. Red data book of Indian plants, vol. 4 (Peninsular India), Calcutta: Botanical Survey of India 1999.
5. Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA. The use and safety of non-allopathic Indian medicines. Drug Safety 2002; 25: 1005-19.
6. Chakravarty BK. Herbal medicines. Safety and Efficacy Guidelines. Regulatory Affairs J 1993; 4: 699-701.
7. Hewawasam RP, JayatilakaKAPW, Pathirana C, Mudduwa LKB. Hepatoprotective effect of Epaltes divaricata extract on carbon tetrachloride induced hepatotoxicity. Indian J Med Res 2004; 120: 30-4.
8. Vijayan.P, Raghu C, Ashok G, Dhanaraj SA, Suresh B. Antiviral activity of medicinal plants of Nilgiris. Indian J Med Res 2004; 120: 24-9.
9. World Health Organisation. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: World Health Organization; 2004 p. 1-133.
10. World Health Organisation. General guidelines for methodologies on research and evaluation of traditional medicine. WHO/EDM/TRM/Geneva: WHO, 2001.
11. Obermeyer WR, Aloi BK, Musser SM, Correll WA Jr, Cichowicz SM, Betz JM, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998; 339: 806-11.
12. Aggarwal KC, Prasad MS, Salhan RN, Yadav D, Pandit N, Goyal PC, et al. A two-centre collaborative study on clinico-epidemiological profile of a recent outbreak of epidemic dropsy in New Delhi (India) with special emphasis on its cardiac manifestations in pediatric patients. J Trop Pediatr 2001; 47: 291-4.
13. Good manufacturing practices: supplementary guidelines for the manufacture of herbal medicinal products Annex 8. WHO Tech Rep Ser, No. 863; 1996.
14. Pal SK, Shukla Y. Herbal medicine: current status and the future. Asian Pac J Cancer Prev 2003; 4: 281-8.
15. Fong HH. Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 2002; 1: 287-93.
16. Ikegami F, Fujii Y, Ishihara K, Satoh T. Toxicological aspects of Kampo medicines in Clinical Use. Chem Biol Interact 2003; 145: 235-50.
17. Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS. Kava lactones and the kava-kava controversy. Phytochemistry 2003; 64: 673-9.
18. Izzo AA. Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharmacol Ther 2004; 42: 139-48.
19. General guidelines for methodologies on research and evaluation of traditional medicine. WHO/EDM/TRM/2000.1 Geneva: WHO; 2000 p. 74.
20. Linde K, Mulrow CD. St John's wort for depression. Cochrane Database Syst Rev 2000; (2): CD000448.
21. Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002; (3): CD001423.
22. Good clinical guidelines for clinical trials on pharmaceutical products in India. New Delhi: Central Drug Stantard Control Organisation. Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, Dec. 2001.